Cargando…
Outcome of retinopathy of prematurity patients following adoption of revised indications for treatment
BACKGROUND: The Early Treatment for Retinopathy of Prematurity study (ETROP), published in 2003, established new guidelines for treatment of retinopathy of prematurity (ROP) and demonstrated improved outcomes compared to previous guidelines. We examined outcomes before and after implementing the ETR...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605435/ https://www.ncbi.nlm.nih.gov/pubmed/19014557 http://dx.doi.org/10.1186/1471-2415-8-23 |
_version_ | 1782162849570750464 |
---|---|
author | Alme, Aaron M Mulhern, Michael L Hejkal, Thomas W Meza, Jane L Qiu, Fang Ingvoldstad, David D Margalit, Eyal |
author_facet | Alme, Aaron M Mulhern, Michael L Hejkal, Thomas W Meza, Jane L Qiu, Fang Ingvoldstad, David D Margalit, Eyal |
author_sort | Alme, Aaron M |
collection | PubMed |
description | BACKGROUND: The Early Treatment for Retinopathy of Prematurity study (ETROP), published in 2003, established new guidelines for treatment of retinopathy of prematurity (ROP) and demonstrated improved outcomes compared to previous guidelines. We examined outcomes before and after implementing the ETROP recommendations. METHODS: A retrospective chart review was performed using records of infants who had laser ablations for ROP performed from January, 2000 through December, 2005. Data collected included date of birth; birth weight; estimated gestational age (EGA); grading of ROP; date of laser ablation; and outcome of laser surgery. Univariate association with threshold or prethreshold treatment (Pre-ETROP and Post-ETROP, respectively) were assessed using t-tests or Wilcoxon tests. Additional comparison between groups was performed using Fisher's exact tests. RESULTS: 581 patients were examined before and 464 after December 2003. Of these, 29/581 (5% – Pre-ETROP Group) and 53/464 (11% – Post-ETROP Group) patients advanced to criteria requiring laser treatment respectively (P = 0.0001). The average estimated gestational age (EGA) at birth was 26.3 and 25.2 weeks, with an average birth weight of 888 and 707 grams for Pre and Post-ETROP Groups, respectively. Stage 5 retinal detachment (RD) developed in 10.3% of eyes in the Pre-ETROP Group and 1.9% of eyes in the Post-ETROP Group (P = 0.02). CONCLUSION: After the ETROP guidelines were implemented, there was a decrease from 10.3% to 1.9% of eyes developing Stage 5 retinal detachment, despite this group having a lower average EGA and lower average birth weight. These results underscore the importance of adoption of the Revised Indications. |
format | Text |
id | pubmed-2605435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26054352008-12-19 Outcome of retinopathy of prematurity patients following adoption of revised indications for treatment Alme, Aaron M Mulhern, Michael L Hejkal, Thomas W Meza, Jane L Qiu, Fang Ingvoldstad, David D Margalit, Eyal BMC Ophthalmol Research Article BACKGROUND: The Early Treatment for Retinopathy of Prematurity study (ETROP), published in 2003, established new guidelines for treatment of retinopathy of prematurity (ROP) and demonstrated improved outcomes compared to previous guidelines. We examined outcomes before and after implementing the ETROP recommendations. METHODS: A retrospective chart review was performed using records of infants who had laser ablations for ROP performed from January, 2000 through December, 2005. Data collected included date of birth; birth weight; estimated gestational age (EGA); grading of ROP; date of laser ablation; and outcome of laser surgery. Univariate association with threshold or prethreshold treatment (Pre-ETROP and Post-ETROP, respectively) were assessed using t-tests or Wilcoxon tests. Additional comparison between groups was performed using Fisher's exact tests. RESULTS: 581 patients were examined before and 464 after December 2003. Of these, 29/581 (5% – Pre-ETROP Group) and 53/464 (11% – Post-ETROP Group) patients advanced to criteria requiring laser treatment respectively (P = 0.0001). The average estimated gestational age (EGA) at birth was 26.3 and 25.2 weeks, with an average birth weight of 888 and 707 grams for Pre and Post-ETROP Groups, respectively. Stage 5 retinal detachment (RD) developed in 10.3% of eyes in the Pre-ETROP Group and 1.9% of eyes in the Post-ETROP Group (P = 0.02). CONCLUSION: After the ETROP guidelines were implemented, there was a decrease from 10.3% to 1.9% of eyes developing Stage 5 retinal detachment, despite this group having a lower average EGA and lower average birth weight. These results underscore the importance of adoption of the Revised Indications. BioMed Central 2008-11-13 /pmc/articles/PMC2605435/ /pubmed/19014557 http://dx.doi.org/10.1186/1471-2415-8-23 Text en Copyright © 2008 Alme et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Alme, Aaron M Mulhern, Michael L Hejkal, Thomas W Meza, Jane L Qiu, Fang Ingvoldstad, David D Margalit, Eyal Outcome of retinopathy of prematurity patients following adoption of revised indications for treatment |
title | Outcome of retinopathy of prematurity patients following adoption of revised indications for treatment |
title_full | Outcome of retinopathy of prematurity patients following adoption of revised indications for treatment |
title_fullStr | Outcome of retinopathy of prematurity patients following adoption of revised indications for treatment |
title_full_unstemmed | Outcome of retinopathy of prematurity patients following adoption of revised indications for treatment |
title_short | Outcome of retinopathy of prematurity patients following adoption of revised indications for treatment |
title_sort | outcome of retinopathy of prematurity patients following adoption of revised indications for treatment |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605435/ https://www.ncbi.nlm.nih.gov/pubmed/19014557 http://dx.doi.org/10.1186/1471-2415-8-23 |
work_keys_str_mv | AT almeaaronm outcomeofretinopathyofprematuritypatientsfollowingadoptionofrevisedindicationsfortreatment AT mulhernmichaell outcomeofretinopathyofprematuritypatientsfollowingadoptionofrevisedindicationsfortreatment AT hejkalthomasw outcomeofretinopathyofprematuritypatientsfollowingadoptionofrevisedindicationsfortreatment AT mezajanel outcomeofretinopathyofprematuritypatientsfollowingadoptionofrevisedindicationsfortreatment AT qiufang outcomeofretinopathyofprematuritypatientsfollowingadoptionofrevisedindicationsfortreatment AT ingvoldstaddavidd outcomeofretinopathyofprematuritypatientsfollowingadoptionofrevisedindicationsfortreatment AT margaliteyal outcomeofretinopathyofprematuritypatientsfollowingadoptionofrevisedindicationsfortreatment |